News Archives - PsychoGenics

GBR Connect Series – Interview with Emer Leahy, PsychoGenics

by Irene Morgenstern | Mar 15, 2022

Can you give an overview of how business has evolved for PsychoGenics over the past year? There are two sides to PsychoGenics; a preclinical CNS focused CRO and drug discovery. On the CRO side, PsychoGenics experienced significant growth with our service business...

PsychoGenics’ High Data Security Standards Are Certified by The NIH

by Eric | Jan 25, 2022

PsychoGenics’ High Data Security Standards Are Certified by The NIH PsychoGenics Inc. (PGI), a provider of AI-based phenotypic platforms and preclinical assays for the development of therapeutics for pain, neurodegenerative, psychiatric, and developmental disorders,...

PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development

by Eric | Dec 14, 2021

PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development PsychoGenics Inc. announced the appointment of Stephen Morairty, Ph.D., as Vice President of...

PsychoGenics Chief Innovation Officer Honored for Scientific Excellence

by Eric | Oct 11, 2021

PsychoGenics Chief Innovation Officer Honored for Scientific Excellence PsychoGenics announces that Daniela Brunner Ph.D., Chief Innovation Officer, was named the recipient of Great Minds in STEMTM (GMiS) Scientist of the Year Award (GMiS 2021 Award Winners). Dr....

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives

by Maxson | Sep 25, 2020

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives Daniela Brunner, Chief Innovation Officer; Geoffrey Varty, Executive Vice President, Research Operations; and Leslie Street, Vice President, Medicinal Chemistry PsychoGenics Inc....

« Older Entries

GBR Connect Series – Interview with Emer Leahy, PsychoGenics

PsychoGenics’ High Data Security Standards Are Certified by The NIH

PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development

PsychoGenics Chief Innovation Officer Honored for Scientific Excellence

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives

Recent Comments

CONTACT